Not applicableUnknownNCT05371392What this trial is testingPolymorphism of ITGA4 Gene in Chronic Lymphocytic LeukemiaWho this might be right forChronic Lymphocytic Leukemia Sohag University 80
Very early researchLooking for participantsNCT07428707What this trial is testingImmune Profiling of CLL/SLL Treated With First-Line PirtobrutinibWho this might be right forChronic Lymphocytic Leukemia (CLL)Small Lymphocytic Lymphoma (SLL) National Heart, Lung, and Blood Institute (NHLBI) 30
Testing effectiveness (Phase 2)Study completedNCT00004907What this trial is testingChemotherapy and Radiation Therapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Refractory T-cell Lymphoma, Hodgkin's Lymphoma, or Non-Hodgkin's LymphomaWho this might be right forLymphoma Northwestern University
Not applicableStudy completedNCT00716911What this trial is testingMeasuring Changes in Blood in Patients at High Risk of Cytomegalovirus Infection After Undergoing Donor Bone Marrow Transplant or Peripheral Blood Stem Cell TransplantWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+4 more City of Hope Medical Center 100
Early research (Phase 1)Ended earlyNCT03103971What this trial is testingHuJCAR014 CAR-T Cells in Treating Adult Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma or Acute Lymphoblastic LeukemiaWho this might be right forRecurrent Adult Acute Lymphoblastic LeukemiaRecurrent B-Cell Non-Hodgkin LymphomaRecurrent Diffuse Large B-Cell Lymphoma+14 more Fred Hutchinson Cancer Center 55
Testing effectiveness (Phase 2)Study completedNCT01125176What this trial is testingAlternating Thalidomide and Lenalidomide Therapy Plus Rituximab (ThRiL) as Initial Treatment for Patients With CLLWho this might be right forChronic Lymphocytic Leukemia Weill Medical College of Cornell University 15
Not applicableEnded earlyNCT01077440What this trial is testingPresence of Donor-Derived DNA in Semen Samples From Cancer Survivors Who Underwent Donor Stem Cell TransplantWho this might be right forCancer SurvivorChronic Myeloproliferative DisordersLeukemia+6 more Vanderbilt University 24
Large-scale testing (Phase 3)Ended earlyNCT00416910What this trial is testingCombination Chemotherapy With or Without G-CSF in Treating Patients With Relapsed Chronic Lymphocytic LeukemiaWho this might be right forChronic Lymphocytic Leukemia German CLL Study Group 83
Testing effectiveness (Phase 2)WithdrawnNCT02371590What this trial is testingLenalidomide and Obinutuzumab for Previously Untreated CLLWho this might be right forChronic Lymphocytic Leukemia University of California, San Diego
Testing effectiveness (Phase 2)Active Not RecruitingNCT02756897What this trial is testingVenetoclax and Ibrutinib in Treating Patients With Chronic or Small Lymphocytic LeukemiaWho this might be right forChronic Lymphocytic LeukemiaRecurrent Chronic Lymphocytic LeukemiaRecurrent Small Lymphocytic Lymphoma+3 more M.D. Anderson Cancer Center 234
Testing effectiveness (Phase 2)Ended earlyNCT05272813What this trial is testingInvestigate the Efficacy and Safety of MS-553 in CLL/SLLWho this might be right forLymphocytic LeukemiaSmall Lymphocytic Lymphoma Shenzhen MingSight Relin Pharmaceuticals Co., Ltd. 13
Early research (Phase 1)Active Not RecruitingNCT01430390What this trial is testingIn Vitro Expanded Allogeneic Epstein-Barr Virus Specific Cytotoxic T-Lymphocytes (EBV-CTLs) Genetically Targeted to the CD19 Antigen in B-cell MalignanciesWho this might be right forAcute Lymphocytic LeukemiaLymphoma Memorial Sloan Kettering Cancer Center 19
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07674810What this trial is testingTrial Of The Combination Of Zanubrutinib, Sonrotoclax, And Obinutuzumab For Patients With Treatment-Naïve Chronic Lymphocytic LeukemiaWho this might be right forChronic Lymphocytic Leukemia M.D. Anderson Cancer Center 40
Early research (Phase 1)Study completedNCT01373229What this trial is testingLenalidomide + Plerixafor in Previously Treated Chronic Lymphocytic Leukemia (CLL)Who this might be right forLeukemia, Lymphocytic, Chronic, B-Cell David Rizzieri, MD 21
Not applicableStudy completedNCT01675102What this trial is testingAllogeneic Hematopoietic Stem Cell Transplantation (HSCT) in 17p- Chronic Lymphocytic Leukemia (CLL)Who this might be right forCLL European Society for Blood and Marrow Transplantation 41
Large-scale testing (Phase 3)Active Not RecruitingNCT01886872What this trial is testingRituximab and Bendamustine Hydrochloride, Rituximab and Ibrutinib, or Ibrutinib Alone in Treating Older Patients With Previously Untreated Chronic Lymphocytic LeukemiaWho this might be right forStage I Chronic Lymphocytic LeukemiaStage II Chronic Lymphocytic LeukemiaStage III Chronic Lymphocytic Leukemia+1 more National Cancer Institute (NCI) 547
Not applicableStudy completedNCT04872621What this trial is testingCalquence CLL rr Japan PMS_Japan Post-Marketing Surveillance (PMS) Study - All Patient InvestigationWho this might be right forRelapsed or Refractory Chronic Lymphocytic Leukemia (Including Small Lymphocytic Lymphoma) AstraZeneca 104
Testing effectiveness (Phase 2)UnknownNCT04714593What this trial is testingTargeting CD19 and CD22 CAR-T Cells Immunotherapy in Patients With Relapsed or Refractory Acute B Lymphocytic LeukemiaWho this might be right forAcute Lymphocytic Leukemia， B-Cell Shanxi Province Cancer Hospital 24
Testing effectiveness (Phase 2)Study completedNCT02458014What this trial is testingBlinatumomab in Treating Patients With B-cell Acute Lymphoblastic Leukemia With Minimal Residual DiseaseWho this might be right forAdult Acute Lymphoblastic Leukemia in Complete RemissionB Acute Lymphoblastic LeukemiaMinimal Residual Disease+1 more M.D. Anderson Cancer Center 36
Testing effectiveness (Phase 2)Study completedNCT01314014What this trial is testingImexon for Relapsed Follicular and Aggressive LymphomasWho this might be right forFollicular LymphomaSmall Lymphocytic LymphomaMarginal Zone Lymphoma+4 more University of Rochester 22